- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07624500
Food and Metabolism Study (FAM)
Effects of Avocado on Triglyceride Metabolism in Individuals With Insulin Resistance
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The proposed study will be conducted in humans according to Good Clinical Practice (GCP) guidelines. All subjects will review and sign an Informed Consent Form approved by the Illinois Institute of Technology's Institutional Review Boards (IRB) prior to screening. The research is designed as a randomized, 2-arm, parallel, diet-controlled, human clinical trial to investigate the effects of avocado consumption for 4 weeks on triglyceride metabolism in individuals with insulin resistance.
Participants will be asked to do the items described below. Visits will be held at the Clinical Nutrition Research Center (CNRC) on the Illinois Tech Campus, 10 W. 35th St., Suite 3D6-1 Chicago, IL, 60616.
SCREENING VISIT
Eligibility for the study is based on the above list (inclusion and exclusion criteria). Investigators will determine if participants qualify for the study at the Screening Visit by the following measurements:
- General measurements: height, weight, body composition, waist circumference, blood pressure, vitals and body temperature
- Fasting blood glucose (sugar) from a finger prick
- Venous blood collection to assess blood glucose, insulin, and triglycerides
- Pregnancy test, for women under the age of 60
Demographic questionnaire, health and medication questionnaire: participants will be asked to provide personal information, such as their name, date of birth, race, etc. Investigators will also ask them to answer questions about their demographics, health, medical history, and the medications they are taking. Based on the results of the blood draw, questionnaires, measurements, and evaluation of their health, they may meet the criteria and be invited to participate in the study.
PRE-STUDY / PRE-INTERVENTION VISIT (which may be performed on the same or a different day as the screening visit) The Pre-Study visit lasts ~45 minutes to 1 hour and participants will meet with one of our investigators who will provide detailed instructions on procedures of the study and "how to prepare for each of participants study days." They will be trained in all study procedures, including, but not limited to, foods to avoid during the study, medications/supplements to avoid, food diary recording, gastrointestinal diary recording and fasting overnight. Their study dates will be scheduled, and they will be provided with a study booklet, including a study calendar and all instructions covered at the Pre-Study Visit.
Medications/Supplements: If they are taking any medications or supplements that do not interfere with the study or have been OK'd by study staff, they will take those as instructed by their doctor and will record them in their diary. Investigators will train the participants on what foods or supplements are OK and NOT OK during the study at the Pre-Study Visit.
Self-Characteristics and Dietary Surveys: Participants will be asked to complete online surveys that cover usual gastrointestinal symptoms and a 24-hour food recall (https://asa24.nih.gov/).
STUDY DAY VISITS Study Visit 1 / Day 0 and Visit 5 / Day 28 Procedures
Staff collects study materials from the participant
1. Diary and provide 24 h recall (https://asa24.nih.gov/) Confirmation participant is ready to go for their study day by interview/discussion with the study staff
- Fasted overnight for 10-12 hours, including finger prick to verify usual fasting glucose
- Had a usual night of sleep (5-6 hours minimum)
- Avoided alcohol and vigorous physical activity 24 hours before the study day
After confirming they are ready for their study day, Investigators will proceed to an exam room to measure:
Anthropometrics: Investigators will measure weight, waist circumference and body composition.
Vital signs: Investigators will check their blood pressure, heart rate, and body temperature using standard clinic devices.
Once Investigators have collected measurements, they will proceed with an IV catheter to collect blood over multiple timepoints.
Blood collection: Participants will see the Licensed Health Care Provider (LHCP) for blood sample collection. Investigators will use an indwelling catheter (IV). This means Investigators will use a needle to put a thin tube in their arm or hand, from which Investigators can get blood samples while keeping them as comfortable as possible. This tube will stay in their arm until all blood drawings are completed during their visit. If there is difficulty with blood flow Investigators will ask the participant if they're comfortable with single stick blood collection, performed by LHCP using a butterfly needle. There will be nine blood draws in total over 5 hours.
Once the fasting blood draw is collected, Investigators will provide the participant with a breakfast in the form of a nutritionally complete liquid meal test (LMT).
Standard Liquid Meal Test (LMT): For this test, they will drink about 2 cups of vanilla flavored Ensure®. Ensure® is a nutritional supplement containing a mixture of sugars, fats, and protein and a variety of vitamins and minerals. The drink contains milk protein (suitable for lactose intolerance) and soy products. Investigators will ask if they are unwilling to consume any ingredients in the Ensure® drink. It may be unsafe for them to complete this test if they have an allergy to any of the components. The total amount participant will drink will be approximately 440 calories, 64g of Carbs, 12g of Fat, and 18g of Protein.
After all blood samples have been collected they will be provided with meals to last until V2 (~ 1 week) and instructed how to fill out the dietary adherence log.
MEAL PICKUP VISITS Study Visit 2 / Day 7, Study Visit 3 / Day 14, Study Visit 4 / Day 21
Participants will not need to come fasted for meal pickup visits. Investigators will collect materials and ensure they are complying with the study protocols, and assess if there are any difficulties Investigators can help with. The following will be done at pickup visits:
Staff collects study materials from the participant 1. Diary and provide 24 h recall (https://asa24.nih.gov/) Staff collects weight and LDN does counseling as needed
1. Licensed Dietitian Nutritionist (LDN) will review compliance diary and weight changes and provide nutrition counseling as needed
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Chelsea Preiss, MS
- Telefoonnummer: 312-567-5300
- E-mail: cpreiss@illinoistech.edu
Studie Contact Back-up
- Naam: Indika Edirisinghe, PhD
- Telefoonnummer: 708-563-8178
- E-mail: iedirisi@illinoistech.edu
Studie Locaties
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60616
- Werving
- Clinical Nutrition Research Center at IIT
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Men or women, 40-70 years of age.
- Fasting triglycerides (TG) >115 mg/dL.
- Insulin resistance as measured by Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) >2.5.
- Able to provide informed consent.
- Able to comply with and perform the procedures requested by the protocol, specifically eat all the meals and snacks provided by the study which will be almost all your food (~ 80% of calories per day).
- Able to come to the clinic up to 6 times during the study.
- Able to maintain usual physical activity pattern.
- Able to avoid/abstain from alcohol and vigorous physical activity for 24 hours prior to and during study visit.
Exclusion Criteria:
- Men and women with known or suspected intolerance, allergies or hypersensitivity to study foods or interventions.
- Fasting blood sugar ≥125 mg/dL. Men and women with blood pressure >160 mmHg (systolic) / 100 mmHg (diastolic) at the screening visit.
- Men and women with history of diabetes cardiovascular events, respiratory, renal, gastrointestinal, hepatic or eye disease or surgery- within a year.
- Men and women who have or had cancer other than non-melanoma skin cancer in the past 5 years.
- Men and women taking over the counter or prescription medications or dietary supplements that may interfere with study procedures or endpoints.
- Men and women who are on a specialized diet (vegan, vegetarian, keto, etc.). - - Men and women who consume nuts or peanuts daily or most days of the week.
- Men and women who are not weight stable (+/-10lbs in previous 2 months). Men and women who have excessive use of drugs or alcohol (ie., addictions) within the past 2 years.
- Men and women with documented physical or mental disease/condition, which might limit participation in or completion of the study or, that, in the opinion of the investigator, could interfere with the interpretation of the study results.
- Women who are known to be pregnant or who are intending to become pregnant over the course of the study.
- Women who are lactating.
- Major trauma or a surgical event within 2 months (or longer depending on trauma or event) and after consultation with PI. Has used antibiotics within the previous 2 months.
- History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating) diagnosed by a health professional.
- Excessive coffee and tea consumers (> 4 cups/d).
- Donated blood within the last 3 months.
- Women who are taking an unstable dose and brand of hormonal contraceptives and/or a stable dose and brand for less than 6 months.
- Unusual working hours (working overnight).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Avocado meal plan
2 meals and snack per day including one avocado in the meal, covering 80% of daily calories need.
|
American Diet with avocado
|
|
Placebo-vergelijker: Control meal plan
2 meals and snacks per day without the inclusion of avocado, covering 80% of daily calories needs.
|
American diet
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in serum biomarker: triglycerides
Tijdsspanne: baseline and 4 weeks
|
analyzed by McLendon labs
|
baseline and 4 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in serum biomarker: insulin
Tijdsspanne: baseline and 4 weeks
|
analyzed by McLendon labs
|
baseline and 4 weeks
|
|
Changes in serum biomarker: glucose
Tijdsspanne: baseline and 4 weeks
|
analyzed by McLendon labs
|
baseline and 4 weeks
|
|
Changes in Muscle Insulin Sensitivity Index (MISI)
Tijdsspanne: baseline and 4 weeks
|
calculated using postprandial glucose and insulin concentrations measured by Randox clinical analyzer
|
baseline and 4 weeks
|
|
Changes in total cholesterol
Tijdsspanne: baseline and 4 weeks
|
fasting state, analyzed by Labcorp
|
baseline and 4 weeks
|
|
Changes in free fatty acids
Tijdsspanne: baseline and 4 weeks
|
analyzed by Quest Diagnostics Lab
|
baseline and 4 weeks
|
|
Fructosamine
Tijdsspanne: baseline and 4 weeks
|
analyzed by Randox clinical analyzer
|
baseline and 4 weeks
|
|
Changes in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
Tijdsspanne: baseline and 4 weeks
|
Calculated from fasting glucose and insulin
|
baseline and 4 weeks
|
|
Changes in Low-Density Lipoprotein (LDL) cholesterol
Tijdsspanne: baseline and 4 weeks
|
fasting state, analyzed by Labcorp
|
baseline and 4 weeks
|
|
Changes in High-Density Lipoprotein (HDL) cholesterol
Tijdsspanne: baseline and 4 weeks
|
fasting state, analyzed by Labcorp
|
baseline and 4 weeks
|
|
Changes in non-High-Density Lipoprotein (HDL) cholesterol
Tijdsspanne: baseline and 4 weeks
|
fasting state, analyzed by Labcorp
|
baseline and 4 weeks
|
|
Changes in Connecting Peptide (C-peptide)
Tijdsspanne: baseline and 4 weeks
|
analyzed by McLendon labs
|
baseline and 4 weeks
|
|
Changes in Glucagon-Like Peptide-1(GLP-1)
Tijdsspanne: baseline and 4 weeks
|
analyzed by Luminex multi-target analyzer
|
baseline and 4 weeks
|
|
Inflammation markers-Interleukin (IL)-6
Tijdsspanne: Baseline
|
Analyzed by Luminex method
|
Baseline
|
|
Inflammation markers-Interleukin (IL)-10
Tijdsspanne: Baseline
|
Analyzed by Luminex method
|
Baseline
|
|
Inflammation markers-Tumor necrosis factor alpha (TNF-α)
Tijdsspanne: Baseline
|
Analyzed by Luminex method
|
Baseline
|
|
Nuclear Magnetic Resonance (NMR) Lipoprotein Subfraction
Tijdsspanne: Baseline
|
Analyzed by Labcorp
|
Baseline
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Britt Burton-Freeman, PhD, Food Sci and Nut Programs
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- IRB-2026-34
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .